PREDNISOLONE TEBUTATE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for prednisolone tebutate and what is the scope of freedom to operate?
Prednisolone tebutate
is the generic ingredient in two branded drugs marketed by Merck and Watson Labs, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.Summary for PREDNISOLONE TEBUTATE
| US Patents: | 0 |
| Tradenames: | 2 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 43 |
| Patent Applications: | 3,412 |
| DailyMed Link: | PREDNISOLONE TEBUTATE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for PREDNISOLONE TEBUTATE
US Patents and Regulatory Information for PREDNISOLONE TEBUTATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs | PREDNISOLONE TEBUTATE | prednisolone tebutate | INJECTABLE;INJECTION | 083362-001 | Feb 17, 1984 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Merck | HYDELTRA-TBA | prednisolone tebutate | INJECTABLE;INJECTION | 010562-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
